tradingkey.logo

Accelerate Diagnostics Inc

AXDX

0.148USD

+0.009+7.25%
Close 05/09, 16:00ETQuotes delayed by 15 min
3.73MMarket Cap
LossP/E TTM

Accelerate Diagnostics Inc

0.148

+0.009+7.25%
More Details of Accelerate Diagnostics Inc Company
Accelerate Diagnostics, Inc. is in vitro diagnostics company engaged in providing solutions for the global challenges of antibiotic resistance and sepsis. Its Accelerate Pheno system and Accelerate PhenoTest BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the optimal antibiotic therapy for infections. The Accelerate PhenoTest BC Kit, which is the test kit for the system, is indicated as an aid, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia and fungemia, both life-threatening conditions with high morbidity and mortality risk. The device provides identification (ID) results followed by antibiotic susceptibility testing (AST) for certain pathogenic bacteria commonly associated with or causing bacteremia. Its other products include Accelerate Pheno system and BC kit, Accelerate Arc system and BC Kit (Accelerate Arc Products), and Accelerate Wave system.
Company Info
Company codeAXDX
Company nameAccelerate Diagnostics Inc
IPO dateOct 27, 1993
Founded at2012
CEOMr. John (Jack) Phillips
Number of employees107
Security typeOrdinary Share
Fiscal year-endOct 27
Address3950 S Country Club Rd Ste 470 Bldg 3-307
CityDENVER
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code80203
Phone13038638088
Websitehttps://acceleratediagnostics.com/
Company codeAXDX
IPO dateOct 27, 1993
Founded at2012
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Jack W. Schuler
Mr. Jack W. Schuler
Independent Director
Independent Director
8.33M
--
Mr. John Patience
Mr. John Patience
Independent Director
Independent Director
897.68K
+28.67%
Mr. David Patience
Mr. David Patience
Chief Financial Officer
Chief Financial Officer
65.33K
+25.28%
Mr. Hany Massarany
Mr. Hany Massarany
Independent Chairman of the Board
Independent Chairman of the Board
39.89K
--
Ms. Louise L. Francesconi
Ms. Louise L. Francesconi
Independent Director
Independent Director
33.56K
--
Ms. Jennifer Regan
Ms. Jennifer Regan
Independent Director
Independent Director
12.63K
--
Mr. Paul Shalhoub
Mr. Paul Shalhoub
Independent Director
Independent Director
--
--
Mr. Gilbert Nathan
Mr. Gilbert Nathan
Independent Director
Independent Director
--
--
Mr. Mark Black
Mr. Mark Black
Independent Director
Independent Director
--
--
Dr. Lawrence Michael (Larry) Mertz, Ph.D.
Dr. Lawrence Michael (Larry) Mertz, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Jack W. Schuler
Mr. Jack W. Schuler
Independent Director
Independent Director
8.33M
--
Mr. John Patience
Mr. John Patience
Independent Director
Independent Director
897.68K
+28.67%
Mr. David Patience
Mr. David Patience
Chief Financial Officer
Chief Financial Officer
65.33K
+25.28%
Mr. Hany Massarany
Mr. Hany Massarany
Independent Chairman of the Board
Independent Chairman of the Board
39.89K
--
Ms. Louise L. Francesconi
Ms. Louise L. Francesconi
Independent Director
Independent Director
33.56K
--
Ms. Jennifer Regan
Ms. Jennifer Regan
Independent Director
Independent Director
12.63K
--
Revenue Breakdown
Currency: USDUpdate time: Sun, Apr 6
Currency: USDUpdate time: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Products
10.22M
87.34%
Services
1.48M
12.66%
By RegionUSD
Name
Revenue
Proportion
Domestic(United States)
10.40M
88.90%
Foreign
1.30M
11.10%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Products
10.22M
87.34%
Services
1.48M
12.66%
Shareholder
Update time: Sun, Feb 23
Update time: Sun, Feb 23
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Schuler (Jack W)
33.04%
Armistice Capital LLC
8.24%
Patience (John)
3.56%
Griffin Asset Management, Inc.
3.38%
The Vanguard Group, Inc.
1.90%
Other
49.87%
Shareholder Statistics
Shareholder
Proportion
Schuler (Jack W)
33.04%
Armistice Capital LLC
8.24%
Patience (John)
3.56%
Griffin Asset Management, Inc.
3.38%
The Vanguard Group, Inc.
1.90%
Other
49.87%
Type
Shareholder
Proportion
Individual Investor
38.31%
Hedge Fund
9.01%
Investment Advisor/Hedge Fund
6.19%
Investment Advisor
2.73%
Research Firm
0.21%
Other
43.55%
Institutional Shareholding
Update time: Mon, Mar 3
Update time: Mon, Mar 3
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
116
13.99M
56.21%
-4.55M
2024Q4
130
14.16M
56.68%
-4.68M
2024Q3
138
14.45M
59.92%
-3.94M
2024Q2
148
14.03M
59.45%
-4.73M
2024Q1
212
12.64M
57.77%
-1.32M
2023Q4
221
9.17M
25.59%
-847.52K
2023Q3
236
9.25M
26.48%
-524.51K
2023Q2
242
9.11M
170.35%
+3.03M
2023Q1
248
5.18M
51.90%
-755.19K
2022Q4
261
5.42M
66.78%
-848.38K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Schuler (Jack W)
8.33M
33.04%
-200.00K
-2.34%
Dec 03, 2024
Armistice Capital LLC
2.08M
8.24%
-23.00K
-1.09%
Dec 31, 2024
Patience (John)
697.68K
2.77%
+16.67K
+2.45%
Mar 15, 2024
Griffin Asset Management, Inc.
1.00M
3.98%
-241.77K
-19.41%
Dec 31, 2024
The Vanguard Group, Inc.
478.09K
1.9%
+5.06K
+1.07%
Dec 31, 2024
Birchview Capital, LP
325.24K
1.29%
--
--
Dec 31, 2024
Phillips (Jack)
163.43K
0.65%
+515.00
+0.32%
Feb 03, 2025
Geode Capital Management, L.L.C.
135.73K
0.54%
+8.78K
+6.91%
Dec 31, 2024
Cannell & Spears LLC
114.52K
0.45%
--
--
Dec 31, 2024
Renaissance Technologies LLC
107.06K
0.42%
+65.98K
+160.63%
Dec 31, 2024
View more
Related ETFs
Update time: Tue, May 6
Update time: Tue, May 6
Name
Proportion
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jul 10, 2023
Merger
10<1
Jul 10, 2023
Merger
10<1
Jul 10, 2023
Merger
10<1
Jul 10, 2023
Merger
10<1
Date
Type
Ratio
Jul 10, 2023
Merger
10<1
Jul 10, 2023
Merger
10<1
Jul 10, 2023
Merger
10<1
Jul 10, 2023
Merger
10<1